PREPARACION DE INHIBIDORES DE LA ANHIDRASA CARBONICA
SE PRESENTAN INHIBIDORES DE LA ANHIDRASA CARBONICA, UTILES EN EL CONTROL DE LA HIPERTENSION OCULAR, Y QUE TIENEN LA FORMULA (I) EN LA QUE R1 Y R2 SE ESCOGEN AMBAS ENTRE H O ALQUILO C1-C4; R3 ES ALQUILO C1-C6 O CH2(CH2)NOR4 EN DONDE R4 ES CH3 O (CH2)NCH3 Y N ES 1 O 4; O (CH2)NAR EN DONDE AR ES FENILO...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | DEASON, MICHAEL E SPROULL, STEVEN J DEAN, WILLIAM D CONROW, RAYMOND E DANTANARAYANA, ANURA P |
description | SE PRESENTAN INHIBIDORES DE LA ANHIDRASA CARBONICA, UTILES EN EL CONTROL DE LA HIPERTENSION OCULAR, Y QUE TIENEN LA FORMULA (I) EN LA QUE R1 Y R2 SE ESCOGEN AMBAS ENTRE H O ALQUILO C1-C4; R3 ES ALQUILO C1-C6 O CH2(CH2)NOR4 EN DONDE R4 ES CH3 O (CH2)NCH3 Y N ES 1 O 4; O (CH2)NAR EN DONDE AR ES FENILO INSUSTITUIDO, 3-METOXIFENILO O 4METOXIFENILO Y N ES 1 O 2. LOS COMPUESTOS SE PREPARAN DESPLAZANDO EL C(2)-CLORO DEL 3-ACETIL-2,5-DICLOROTIOFENO CON MERCAPTURO DE BENZIL PARA FORMAR EL TIOETER DE LA ESTRUCTURA, QUE SE CONVIERTE ENTONCES EN 3-ACETIL-5-CLORO-2-TIOFENOSULFUNAMIDA MEDIANTE SU REACCION CON CLORO PARA FORMAR CLORURO DE 3-ACETIL-5-CLORO-2-TIOFENOSULFENIL, SEGUIDA POR LA REACCION CON AMONIACO PARA FORMAR 3-ACETIL-5-CLORO-2TIOSULFENAMIDO, Y FINALMENTE SU OXIDACION. LA BROMACION SUMINISTRA 3-BROMOACETIL-5-CLORO-2-TIOFENOSULFONAMIDA QUE SE CONVIERTE EN (S)3,4-DIHIDRO-6-CLORO-4-HIDROXI-2H-TIENO[3,2-E]-1,2-TRIACINA-1, 1DIOXIDO POR REDUCCION CON (-)-(BETA)-CLORODISOPINO-CARBONILBORANO SEGUIDOPOR EL TRATAMIENTO CON UNA BASE ACUOSA. LA ALQUILACION EN N(2) SUMINISTRA EL (S)-3,4-DIHIDRO-6-CLORO-4-HIDROXI-2-2H-TIENO[3,2-E]1,2-TIAZINA-1,1-DIOXIDO. LA FORMACION DEL ANION C(6) SE LLEVA A CABO POR INTERCAMBIO DE HALOGENO-METAL Y EL ANION SE HACE REACCIONAR CON DIOXIDO DE AZUFRE PARA FORMAR SULFINATO DE LITIO, QUE DESPUES DE SU REACCION ACIDO HIDROXILAMINO-O-SULFONICO SUMINISTRA EL (S)-3,4DIHIDRO-4-HIDROXI-2H-TIENO[3,2-E]-1,2-TIAZINA-6-SULFONAMIDA-1,1DIOXIDO. LA PROTECCION DE LA FUNCIONALIDAD DEL C(6)-SULFONAMIDA, SEGUIDA POR LA ACTIVACION DEL C(4)-HIDROXIL Y EL DESPLAZAMIENTO CON UN AMINO APROPIADO SUMINISTRA EL (R)-3,4-DIHIDRO-4-ALQUILAMINO-2HTIENO[3,2-E]-1,2-TIACINA-6-SULFONAMIDO-1,1-DIOXIDO.
Carbonic anhydrase inhibitors, useful in the control of ocular hypertension, and having the formula: wherein: R1 and R2 are both chosen from H or C1-4 alkyl; R3 = C1-6 alkyl or CH2(CH2)nOR4 where R4=CH3 or (CH2)nCH3 and n = 1-4; or (CH2)nAr where Ar = unsubstituted phenyl, 3-methoxyphenyl, or 4-methoxyphenyl and n = 1 or 2. are prepared by displacing the C(2)-chloro of 3-acetyl- 2,5-dichlorothiophene with benzyl mercaptide to form the thioether of structure, which is then converted to 3-acetyl-5-chloro-2-thiophenesulfonamide by reaction with chlorine to form 3-acetyl-5-chloro-2-thiophenesulfenyl chloride, followed by reaction with ammonia to form 3-acetyl-5-chloro-2-thiophenesulfenamide, and finally oxidation. Bromination provides 3-bromoacetyl-5-chloro- 2-thiophenesulfonamide |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2160613TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2160613TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2160613TT33</originalsourceid><addsrcrecordid>eNrjZDAJCHINcAxydPb091NwcVXw9PPwdPJ08Q9yDQZxfRwVHIEiLkGOwY4Kzo5BTv5-ns6OPAysaYk5xam8UJqbQdHNNcTZQze1ID8-tbggMTk1L7Uk3jXYyNDMwMzQOCTE2JgYNQCfaydT</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PREPARACION DE INHIBIDORES DE LA ANHIDRASA CARBONICA</title><source>esp@cenet</source><creator>DEASON, MICHAEL E ; SPROULL, STEVEN J ; DEAN, WILLIAM D ; CONROW, RAYMOND E ; DANTANARAYANA, ANURA P</creator><creatorcontrib>DEASON, MICHAEL E ; SPROULL, STEVEN J ; DEAN, WILLIAM D ; CONROW, RAYMOND E ; DANTANARAYANA, ANURA P</creatorcontrib><description>SE PRESENTAN INHIBIDORES DE LA ANHIDRASA CARBONICA, UTILES EN EL CONTROL DE LA HIPERTENSION OCULAR, Y QUE TIENEN LA FORMULA (I) EN LA QUE R1 Y R2 SE ESCOGEN AMBAS ENTRE H O ALQUILO C1-C4; R3 ES ALQUILO C1-C6 O CH2(CH2)NOR4 EN DONDE R4 ES CH3 O (CH2)NCH3 Y N ES 1 O 4; O (CH2)NAR EN DONDE AR ES FENILO INSUSTITUIDO, 3-METOXIFENILO O 4METOXIFENILO Y N ES 1 O 2. LOS COMPUESTOS SE PREPARAN DESPLAZANDO EL C(2)-CLORO DEL 3-ACETIL-2,5-DICLOROTIOFENO CON MERCAPTURO DE BENZIL PARA FORMAR EL TIOETER DE LA ESTRUCTURA, QUE SE CONVIERTE ENTONCES EN 3-ACETIL-5-CLORO-2-TIOFENOSULFUNAMIDA MEDIANTE SU REACCION CON CLORO PARA FORMAR CLORURO DE 3-ACETIL-5-CLORO-2-TIOFENOSULFENIL, SEGUIDA POR LA REACCION CON AMONIACO PARA FORMAR 3-ACETIL-5-CLORO-2TIOSULFENAMIDO, Y FINALMENTE SU OXIDACION. LA BROMACION SUMINISTRA 3-BROMOACETIL-5-CLORO-2-TIOFENOSULFONAMIDA QUE SE CONVIERTE EN (S)3,4-DIHIDRO-6-CLORO-4-HIDROXI-2H-TIENO[3,2-E]-1,2-TRIACINA-1, 1DIOXIDO POR REDUCCION CON (-)-(BETA)-CLORODISOPINO-CARBONILBORANO SEGUIDOPOR EL TRATAMIENTO CON UNA BASE ACUOSA. LA ALQUILACION EN N(2) SUMINISTRA EL (S)-3,4-DIHIDRO-6-CLORO-4-HIDROXI-2-2H-TIENO[3,2-E]1,2-TIAZINA-1,1-DIOXIDO. LA FORMACION DEL ANION C(6) SE LLEVA A CABO POR INTERCAMBIO DE HALOGENO-METAL Y EL ANION SE HACE REACCIONAR CON DIOXIDO DE AZUFRE PARA FORMAR SULFINATO DE LITIO, QUE DESPUES DE SU REACCION ACIDO HIDROXILAMINO-O-SULFONICO SUMINISTRA EL (S)-3,4DIHIDRO-4-HIDROXI-2H-TIENO[3,2-E]-1,2-TIAZINA-6-SULFONAMIDA-1,1DIOXIDO. LA PROTECCION DE LA FUNCIONALIDAD DEL C(6)-SULFONAMIDA, SEGUIDA POR LA ACTIVACION DEL C(4)-HIDROXIL Y EL DESPLAZAMIENTO CON UN AMINO APROPIADO SUMINISTRA EL (R)-3,4-DIHIDRO-4-ALQUILAMINO-2HTIENO[3,2-E]-1,2-TIACINA-6-SULFONAMIDO-1,1-DIOXIDO.
Carbonic anhydrase inhibitors, useful in the control of ocular hypertension, and having the formula: wherein: R1 and R2 are both chosen from H or C1-4 alkyl; R3 = C1-6 alkyl or CH2(CH2)nOR4 where R4=CH3 or (CH2)nCH3 and n = 1-4; or (CH2)nAr where Ar = unsubstituted phenyl, 3-methoxyphenyl, or 4-methoxyphenyl and n = 1 or 2. are prepared by displacing the C(2)-chloro of 3-acetyl- 2,5-dichlorothiophene with benzyl mercaptide to form the thioether of structure, which is then converted to 3-acetyl-5-chloro-2-thiophenesulfonamide by reaction with chlorine to form 3-acetyl-5-chloro-2-thiophenesulfenyl chloride, followed by reaction with ammonia to form 3-acetyl-5-chloro-2-thiophenesulfenamide, and finally oxidation. Bromination provides 3-bromoacetyl-5-chloro- 2-thiophenesulfonamide which is converted to (S)-3,4- dihydro-6-chloro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide by reduction with (+)- beta -chlorodisopinocampheylborane followed by treatment with aqueous base. Alkylation at N(2) provides the (S)-3,4-dihydro-6-chloro-4-hydroxy-2-substituted-2H-thieno[3,2-e]-1,2- thiazine-1, 1-dioxide. Formation of the C(6) anion is accomplished by halogen-metal exchange, and the anion is reacted with sulfur dioxide to form a lithium sulfinate, which upon reaction with hydroxylamine-O-sulfonic acid provides the (S)-3,4-dihydro-4-hydroxy-2-substituted-2H-thieno[3,2-e]-1,2-thiazine- 6-sulfonamide-1, 1-dioxide. Protection of the C(6)-sulfonamide functionality, followed by activation of the C(4)-hydroxyl and displacement with an appropriate amine provides the (R)-3,4-dihydro-4-alkylamino-2-substituted-2H-thieno[3,2-e]-1,2-thiazi ne-6-sulfonamide-1,1-dioxide.</description><edition>7</edition><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2001</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20011116&DB=EPODOC&CC=ES&NR=2160613T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20011116&DB=EPODOC&CC=ES&NR=2160613T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DEASON, MICHAEL E</creatorcontrib><creatorcontrib>SPROULL, STEVEN J</creatorcontrib><creatorcontrib>DEAN, WILLIAM D</creatorcontrib><creatorcontrib>CONROW, RAYMOND E</creatorcontrib><creatorcontrib>DANTANARAYANA, ANURA P</creatorcontrib><title>PREPARACION DE INHIBIDORES DE LA ANHIDRASA CARBONICA</title><description>SE PRESENTAN INHIBIDORES DE LA ANHIDRASA CARBONICA, UTILES EN EL CONTROL DE LA HIPERTENSION OCULAR, Y QUE TIENEN LA FORMULA (I) EN LA QUE R1 Y R2 SE ESCOGEN AMBAS ENTRE H O ALQUILO C1-C4; R3 ES ALQUILO C1-C6 O CH2(CH2)NOR4 EN DONDE R4 ES CH3 O (CH2)NCH3 Y N ES 1 O 4; O (CH2)NAR EN DONDE AR ES FENILO INSUSTITUIDO, 3-METOXIFENILO O 4METOXIFENILO Y N ES 1 O 2. LOS COMPUESTOS SE PREPARAN DESPLAZANDO EL C(2)-CLORO DEL 3-ACETIL-2,5-DICLOROTIOFENO CON MERCAPTURO DE BENZIL PARA FORMAR EL TIOETER DE LA ESTRUCTURA, QUE SE CONVIERTE ENTONCES EN 3-ACETIL-5-CLORO-2-TIOFENOSULFUNAMIDA MEDIANTE SU REACCION CON CLORO PARA FORMAR CLORURO DE 3-ACETIL-5-CLORO-2-TIOFENOSULFENIL, SEGUIDA POR LA REACCION CON AMONIACO PARA FORMAR 3-ACETIL-5-CLORO-2TIOSULFENAMIDO, Y FINALMENTE SU OXIDACION. LA BROMACION SUMINISTRA 3-BROMOACETIL-5-CLORO-2-TIOFENOSULFONAMIDA QUE SE CONVIERTE EN (S)3,4-DIHIDRO-6-CLORO-4-HIDROXI-2H-TIENO[3,2-E]-1,2-TRIACINA-1, 1DIOXIDO POR REDUCCION CON (-)-(BETA)-CLORODISOPINO-CARBONILBORANO SEGUIDOPOR EL TRATAMIENTO CON UNA BASE ACUOSA. LA ALQUILACION EN N(2) SUMINISTRA EL (S)-3,4-DIHIDRO-6-CLORO-4-HIDROXI-2-2H-TIENO[3,2-E]1,2-TIAZINA-1,1-DIOXIDO. LA FORMACION DEL ANION C(6) SE LLEVA A CABO POR INTERCAMBIO DE HALOGENO-METAL Y EL ANION SE HACE REACCIONAR CON DIOXIDO DE AZUFRE PARA FORMAR SULFINATO DE LITIO, QUE DESPUES DE SU REACCION ACIDO HIDROXILAMINO-O-SULFONICO SUMINISTRA EL (S)-3,4DIHIDRO-4-HIDROXI-2H-TIENO[3,2-E]-1,2-TIAZINA-6-SULFONAMIDA-1,1DIOXIDO. LA PROTECCION DE LA FUNCIONALIDAD DEL C(6)-SULFONAMIDA, SEGUIDA POR LA ACTIVACION DEL C(4)-HIDROXIL Y EL DESPLAZAMIENTO CON UN AMINO APROPIADO SUMINISTRA EL (R)-3,4-DIHIDRO-4-ALQUILAMINO-2HTIENO[3,2-E]-1,2-TIACINA-6-SULFONAMIDO-1,1-DIOXIDO.
Carbonic anhydrase inhibitors, useful in the control of ocular hypertension, and having the formula: wherein: R1 and R2 are both chosen from H or C1-4 alkyl; R3 = C1-6 alkyl or CH2(CH2)nOR4 where R4=CH3 or (CH2)nCH3 and n = 1-4; or (CH2)nAr where Ar = unsubstituted phenyl, 3-methoxyphenyl, or 4-methoxyphenyl and n = 1 or 2. are prepared by displacing the C(2)-chloro of 3-acetyl- 2,5-dichlorothiophene with benzyl mercaptide to form the thioether of structure, which is then converted to 3-acetyl-5-chloro-2-thiophenesulfonamide by reaction with chlorine to form 3-acetyl-5-chloro-2-thiophenesulfenyl chloride, followed by reaction with ammonia to form 3-acetyl-5-chloro-2-thiophenesulfenamide, and finally oxidation. Bromination provides 3-bromoacetyl-5-chloro- 2-thiophenesulfonamide which is converted to (S)-3,4- dihydro-6-chloro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide by reduction with (+)- beta -chlorodisopinocampheylborane followed by treatment with aqueous base. Alkylation at N(2) provides the (S)-3,4-dihydro-6-chloro-4-hydroxy-2-substituted-2H-thieno[3,2-e]-1,2- thiazine-1, 1-dioxide. Formation of the C(6) anion is accomplished by halogen-metal exchange, and the anion is reacted with sulfur dioxide to form a lithium sulfinate, which upon reaction with hydroxylamine-O-sulfonic acid provides the (S)-3,4-dihydro-4-hydroxy-2-substituted-2H-thieno[3,2-e]-1,2-thiazine- 6-sulfonamide-1, 1-dioxide. Protection of the C(6)-sulfonamide functionality, followed by activation of the C(4)-hydroxyl and displacement with an appropriate amine provides the (R)-3,4-dihydro-4-alkylamino-2-substituted-2H-thieno[3,2-e]-1,2-thiazi ne-6-sulfonamide-1,1-dioxide.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2001</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAJCHINcAxydPb091NwcVXw9PPwdPJ08Q9yDQZxfRwVHIEiLkGOwY4Kzo5BTv5-ns6OPAysaYk5xam8UJqbQdHNNcTZQze1ID8-tbggMTk1L7Uk3jXYyNDMwMzQOCTE2JgYNQCfaydT</recordid><startdate>20011116</startdate><enddate>20011116</enddate><creator>DEASON, MICHAEL E</creator><creator>SPROULL, STEVEN J</creator><creator>DEAN, WILLIAM D</creator><creator>CONROW, RAYMOND E</creator><creator>DANTANARAYANA, ANURA P</creator><scope>EVB</scope></search><sort><creationdate>20011116</creationdate><title>PREPARACION DE INHIBIDORES DE LA ANHIDRASA CARBONICA</title><author>DEASON, MICHAEL E ; SPROULL, STEVEN J ; DEAN, WILLIAM D ; CONROW, RAYMOND E ; DANTANARAYANA, ANURA P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2160613TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2001</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DEASON, MICHAEL E</creatorcontrib><creatorcontrib>SPROULL, STEVEN J</creatorcontrib><creatorcontrib>DEAN, WILLIAM D</creatorcontrib><creatorcontrib>CONROW, RAYMOND E</creatorcontrib><creatorcontrib>DANTANARAYANA, ANURA P</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DEASON, MICHAEL E</au><au>SPROULL, STEVEN J</au><au>DEAN, WILLIAM D</au><au>CONROW, RAYMOND E</au><au>DANTANARAYANA, ANURA P</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PREPARACION DE INHIBIDORES DE LA ANHIDRASA CARBONICA</title><date>2001-11-16</date><risdate>2001</risdate><abstract>SE PRESENTAN INHIBIDORES DE LA ANHIDRASA CARBONICA, UTILES EN EL CONTROL DE LA HIPERTENSION OCULAR, Y QUE TIENEN LA FORMULA (I) EN LA QUE R1 Y R2 SE ESCOGEN AMBAS ENTRE H O ALQUILO C1-C4; R3 ES ALQUILO C1-C6 O CH2(CH2)NOR4 EN DONDE R4 ES CH3 O (CH2)NCH3 Y N ES 1 O 4; O (CH2)NAR EN DONDE AR ES FENILO INSUSTITUIDO, 3-METOXIFENILO O 4METOXIFENILO Y N ES 1 O 2. LOS COMPUESTOS SE PREPARAN DESPLAZANDO EL C(2)-CLORO DEL 3-ACETIL-2,5-DICLOROTIOFENO CON MERCAPTURO DE BENZIL PARA FORMAR EL TIOETER DE LA ESTRUCTURA, QUE SE CONVIERTE ENTONCES EN 3-ACETIL-5-CLORO-2-TIOFENOSULFUNAMIDA MEDIANTE SU REACCION CON CLORO PARA FORMAR CLORURO DE 3-ACETIL-5-CLORO-2-TIOFENOSULFENIL, SEGUIDA POR LA REACCION CON AMONIACO PARA FORMAR 3-ACETIL-5-CLORO-2TIOSULFENAMIDO, Y FINALMENTE SU OXIDACION. LA BROMACION SUMINISTRA 3-BROMOACETIL-5-CLORO-2-TIOFENOSULFONAMIDA QUE SE CONVIERTE EN (S)3,4-DIHIDRO-6-CLORO-4-HIDROXI-2H-TIENO[3,2-E]-1,2-TRIACINA-1, 1DIOXIDO POR REDUCCION CON (-)-(BETA)-CLORODISOPINO-CARBONILBORANO SEGUIDOPOR EL TRATAMIENTO CON UNA BASE ACUOSA. LA ALQUILACION EN N(2) SUMINISTRA EL (S)-3,4-DIHIDRO-6-CLORO-4-HIDROXI-2-2H-TIENO[3,2-E]1,2-TIAZINA-1,1-DIOXIDO. LA FORMACION DEL ANION C(6) SE LLEVA A CABO POR INTERCAMBIO DE HALOGENO-METAL Y EL ANION SE HACE REACCIONAR CON DIOXIDO DE AZUFRE PARA FORMAR SULFINATO DE LITIO, QUE DESPUES DE SU REACCION ACIDO HIDROXILAMINO-O-SULFONICO SUMINISTRA EL (S)-3,4DIHIDRO-4-HIDROXI-2H-TIENO[3,2-E]-1,2-TIAZINA-6-SULFONAMIDA-1,1DIOXIDO. LA PROTECCION DE LA FUNCIONALIDAD DEL C(6)-SULFONAMIDA, SEGUIDA POR LA ACTIVACION DEL C(4)-HIDROXIL Y EL DESPLAZAMIENTO CON UN AMINO APROPIADO SUMINISTRA EL (R)-3,4-DIHIDRO-4-ALQUILAMINO-2HTIENO[3,2-E]-1,2-TIACINA-6-SULFONAMIDO-1,1-DIOXIDO.
Carbonic anhydrase inhibitors, useful in the control of ocular hypertension, and having the formula: wherein: R1 and R2 are both chosen from H or C1-4 alkyl; R3 = C1-6 alkyl or CH2(CH2)nOR4 where R4=CH3 or (CH2)nCH3 and n = 1-4; or (CH2)nAr where Ar = unsubstituted phenyl, 3-methoxyphenyl, or 4-methoxyphenyl and n = 1 or 2. are prepared by displacing the C(2)-chloro of 3-acetyl- 2,5-dichlorothiophene with benzyl mercaptide to form the thioether of structure, which is then converted to 3-acetyl-5-chloro-2-thiophenesulfonamide by reaction with chlorine to form 3-acetyl-5-chloro-2-thiophenesulfenyl chloride, followed by reaction with ammonia to form 3-acetyl-5-chloro-2-thiophenesulfenamide, and finally oxidation. Bromination provides 3-bromoacetyl-5-chloro- 2-thiophenesulfonamide which is converted to (S)-3,4- dihydro-6-chloro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide by reduction with (+)- beta -chlorodisopinocampheylborane followed by treatment with aqueous base. Alkylation at N(2) provides the (S)-3,4-dihydro-6-chloro-4-hydroxy-2-substituted-2H-thieno[3,2-e]-1,2- thiazine-1, 1-dioxide. Formation of the C(6) anion is accomplished by halogen-metal exchange, and the anion is reacted with sulfur dioxide to form a lithium sulfinate, which upon reaction with hydroxylamine-O-sulfonic acid provides the (S)-3,4-dihydro-4-hydroxy-2-substituted-2H-thieno[3,2-e]-1,2-thiazine- 6-sulfonamide-1, 1-dioxide. Protection of the C(6)-sulfonamide functionality, followed by activation of the C(4)-hydroxyl and displacement with an appropriate amine provides the (R)-3,4-dihydro-4-alkylamino-2-substituted-2H-thieno[3,2-e]-1,2-thiazi ne-6-sulfonamide-1,1-dioxide.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | spa |
recordid | cdi_epo_espacenet_ES2160613TT3 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | PREPARACION DE INHIBIDORES DE LA ANHIDRASA CARBONICA |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A23%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DEASON,%20MICHAEL%20E&rft.date=2001-11-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2160613TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |